A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

Micheal R. Grever; Jacqueline Benedetti; Stanley P. Balcerzak; Sarah A. Taylor; Thomas P. Miller; Shaker R. Dakhil

doi:10.1007/BF00873969

A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

Micheal R. Grever, Jacqueline Benedetti, Stanley P. Balcerzak, Sarah A. Taylor, Thomas P. Miller, Shaker R. Dakhil

English

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	259-261
Number of pages	3
Journal	Investigational New Drugs
Volume	12
Issue number	3
DOIs	https://doi.org/10.1007/BF00873969
State	Published - Sep 1994

ASJC Scopus subject areas

Oncology
Pharmacology
Pharmacology (medical)

Access to Document

10.1007/BF00873969

Cite this

@article{84c688ab5a3146f0bc4b9b4a0151265b,

title = "A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma",

author = "Grever, {Micheal R.} and Jacqueline Benedetti and Balcerzak, {Stanley P.} and Taylor, {Sarah A.} and Miller, {Thomas P.} and Dakhil, {Shaker R.}",

year = "1994",

month = sep,

doi = "10.1007/BF00873969",

language = "English (US)",

volume = "12",

pages = "259--261",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Kluwer Academic Publishers",

number = "3",

}

TY - JOUR

T1 - A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

AU - Grever, Micheal R.

AU - Benedetti, Jacqueline

AU - Balcerzak, Stanley P.

AU - Taylor, Sarah A.

AU - Miller, Thomas P.

AU - Dakhil, Shaker R.

PY - 1994/9

Y1 - 1994/9

UR - http://www.scopus.com/inward/record.url?scp=0028171878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028171878&partnerID=8YFLogxK

U2 - 10.1007/BF00873969

DO - 10.1007/BF00873969

M3 - Article

C2 - 7534752

AN - SCOPUS:0028171878

SN - 0167-6997

VL - 12

SP - 259

EP - 261

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 3

ER -

A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this